Lv3
308 积分 2025-04-08 加入
A multicenter phase 2 trial in children and young adults with newly diagnosed T-ALL: ALL-T11/ T-ALL-211-U from the Japan Children's Cancer Group and the Japan Adult Leukemia Study Group
1个月前
已关闭
Toward Equitable Risk Classification for All Patients with T-ALL
1个月前
已完结
Management and outcomes of patients diagnosed with chronic myeloid leukemia in blast Phase: A multicenter analysis by the h jean khoury cure CML consortium
1个月前
已关闭
Nilotinib versus imatinib with early switch from imatinib tonilotinib to obtain treatment-free remission in newly diagnosedchronic myeloid leukemia patients: the analysis of the frstco-primary endpoint
2个月前
已完结
Efficacy, safety and predictive biomarker of third‐generation tyrosine kinase inhibitors with azacitidine in myeloid blast phase of chronic myeloid leukemia
2个月前
已完结
SUMOylation facilitates the stability of BCR-ABL to promote chronic myeloid leukemia progression
2个月前
已完结
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
2个月前
已完结
Incidence, mortality, and survival associated with acute leukaemiasubtypes by age group in China: a population-based cancer registryanalysis and cohort study
3个月前
已完结
EXTENDED LONG TERM FOLLOW UP AND THE SURVIVAL OF STOP IMATINIBSTUDY(STIM1)
3个月前
已完结
皖公网安备34019202002308
